Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026)
Protalix BioTherapeutics' (PLX) quarterly Interest & Investment Income came in at $188000.0 in Q1 2026, down 55.13% year-on-year from $419000.0 in Q1 2025, and down 29.32% quarter-over-quarter from $266000.0 in Q4 2025.
Protalix BioTherapeutics (PLX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Protalix BioTherapeutics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $188000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 55.13% year-over-year to $188000.0 in Q1 2026; TTM through Mar 2026 was $1.0 million, a 23.91% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 16.63% from the prior year.
- Interest & Investment Income retreated to $188000.0 in Q1 2026 per PLX's latest filing, from $266000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $419000.0 in Q1 2025 and bottomed at $188000.0 in Q1 2026.
- The 3-year median for Interest & Investment Income is $280500.0 (2025), against an average of $293625.0.
- Across the five-year window, Interest & Investment Income jumped 36.32% in 2025 and tumbled 55.13% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $329000.0 in 2024, then declined by 19.15% to $266000.0 in 2025, then decreased by 29.32% to $188000.0 in 2026.
- Per Business Quant, the three latest PLX Interest & Investment Income figures stand at $188000.0 (Q1 2026), $266000.0 (Q4 2025), and $289000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Protalix BioTherapeutics | 189.64 Mn | 178.85 Mn | 29.62 Mn | 188,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 266,000.00 |
| Sep 30, 2025 | 289,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 419,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 212,000.00 |
| Jun 30, 2024 | 374,000.00 |